Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mapstone

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Neurology|May 7, 2026
Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down SyndromePaul A Chung, Victoria L Fleming, Kathryn J Reid, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Plasma NT1-tau and Aβ <sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohortsAndrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Parkinsonism & Related Disorders|October 6, 2012
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's diseaseMelissa J Armstrong, Sarah Duff-Canning, David F Tang-Wai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLisa M Taylor, Jenna N Adams, Natalie DiProspero, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoringMelissa E Petersen, Lisi Flores-Aguilar, Elizabeth Head, et al.
JAMA Neurology|July 5, 2022
Detection of Brain Tau Pathology in Down Syndrome Using Plasma BiomarkersShorena Janelidze, Bradley T Christian, Julie Price, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) miceSage J B Dunham, Julio Avelar-Barragan, Jason A Rothman, et al.
Geroscience|May 18, 2022
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's diseaseFabio Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain studyAnum Saeed, Yuefang Chang, Justin Swanson, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Neurology|May 7, 2026
Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down SyndromePaul A Chung, Victoria L Fleming, Kathryn J Reid, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Plasma NT1-tau and Aβ <sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohortsAndrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Parkinsonism & Related Disorders|October 6, 2012
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's diseaseMelissa J Armstrong, Sarah Duff-Canning, David F Tang-Wai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLisa M Taylor, Jenna N Adams, Natalie DiProspero, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoringMelissa E Petersen, Lisi Flores-Aguilar, Elizabeth Head, et al.
JAMA Neurology|July 5, 2022
Detection of Brain Tau Pathology in Down Syndrome Using Plasma BiomarkersShorena Janelidze, Bradley T Christian, Julie Price, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) miceSage J B Dunham, Julio Avelar-Barragan, Jason A Rothman, et al.
Geroscience|May 18, 2022
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's diseaseFabio Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2025
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain studyAnum Saeed, Yuefang Chang, Justin Swanson, et al.
Pageof 15